Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1982 4
1983 1
1984 1
1985 2
1988 5
1989 2
1990 5
1991 3
1992 6
1993 4
1994 6
1995 10
1996 12
1997 5
1998 11
1999 13
2000 19
2001 17
2002 20
2003 21
2004 24
2005 14
2006 16
2007 15
2008 22
2009 16
2010 21
2011 15
2012 12
2013 25
2014 25
2015 21
2016 22
2017 28
2018 21
2019 20
2020 31
2021 31
2022 35
2023 29
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

563 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Elusakin
Page 1
Did you mean tobi elisa in (31 results)?
Tobramycin.
[No authors listed] [No authors listed] 2021 Feb 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2021 Feb 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000174 Free Books & Documents. Review.
Inhaled tobramycin (TOBI).
Bonsignore CL. Bonsignore CL. Pediatr Nurs. 1998 May-Jun;24(3):258-9. Pediatr Nurs. 1998. PMID: 9987427 Review.
The new product, manufactured by PathoGenesis Corporation, is referred to as TOBI and is indicated for cystic fibrosis patients with Pseudomonas aeruginosa. ...
The new product, manufactured by PathoGenesis Corporation, is referred to as TOBI and is indicated for cystic fibrosis patients with …
Acute knee pain.
Oputa TJ, Jain N. Oputa TJ, et al. BMJ. 2023 Jul 6;382:e075577. doi: 10.1136/bmj-2023-075577. BMJ. 2023. PMID: 37414429 No abstract available.
Editorial: Health inequity: from evidence to action.
Linehan C, Naaldenberg J, van Schrojenstein Lantman de Valk H, Tobi H. Linehan C, et al. J Appl Res Intellect Disabil. 2015 Jan;28(1):1-2. doi: 10.1111/jar.12136. J Appl Res Intellect Disabil. 2015. PMID: 25530569 No abstract available.
The use of tobramycin for Pseudomonas aeruginosa: a review.
Fiel SB, Roesch EA. Fiel SB, et al. Expert Rev Respir Med. 2022 May;16(5):503-509. doi: 10.1080/17476348.2022.2057951. Epub 2022 Apr 4. Expert Rev Respir Med. 2022. PMID: 35320051 Review.
Tobramycin has in vitro activity against Gram-negative bacteria, including P. aeruginosa, and TOBI Podhaler is indicated for the management of individuals with cystic fibrosis with P. aeruginosa infection. ...
Tobramycin has in vitro activity against Gram-negative bacteria, including P. aeruginosa, and TOBI Podhaler is indicated for the mana …
TOBI: reducing the impact of pseudomonal infection.
Govan J. Govan J. Hosp Med. 2002 Jul;63(7):421-5. doi: 10.12968/hosp.2002.63.7.1987. Hosp Med. 2002. PMID: 12187603 Review.
Pseudomonas aeruginosa infection is associated with impaired lung function and reduced life expectancy in cystic fibrosis patients. Tobramycin nebulizer solution (TOBI, Chiron Corporation Ltd, Hounslow) has been specifically formulated for use against P. aeruginosa infecti …
Pseudomonas aeruginosa infection is associated with impaired lung function and reduced life expectancy in cystic fibrosis patients. Tobramyc …
[TOBI Podhaler for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis patients].
Pierart F. Pierart F. Rev Med Liege. 2013 Sep;68(9):486-8. Rev Med Liege. 2013. PMID: 24180205 Free article. Review. French.
TOBI Podhaler is the first dry powder formulation of tobramycin for inhaled therapy of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients from the age of 6 years. Clinical studies show a safety and efficacy profile comparable to tobramycin inhaled solutio …
TOBI Podhaler is the first dry powder formulation of tobramycin for inhaled therapy of chronic Pseudomonas aeruginosa infection in cy …
563 results